Literature DB >> 17178787

Selection for simple major surface protein 2 variants during Anaplasma marginale transmission to immunologically naïve animals.

Guy H Palmer1, James E Futse, Christina K Leverich, Donald P Knowles, Fred R Rurangirwa, Kelly A Brayton.   

Abstract

Anaplasma marginale, a rickettsial pathogen, evades clearance in the animal host by antigenic variation. Under immune selection, A. marginale expresses complex major surface protein 2 mosaics, derived from multiple donor sequences. However, these mosaics have a selective advantage only in the presence of adaptive immunity and are rapidly replaced by simple variants following transmission.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17178787      PMCID： PMC1828556          DOI： 10.1128/IAI.01801-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  23 in total

1.  Efficient use of a small genome to generate antigenic diversity in tick-borne ehrlichial pathogens.

Authors:  K A Brayton; D P Knowles; T C McGuire; G H Palmer
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

2.  Antigenic variation of Anaplasma marginale msp2 occurs by combinatorial gene conversion.

Authors:  Kelly A Brayton; Guy H Palmer; Anna Lundgren; Jooyoung Yi; Anthony F Barbet
Journal:  Mol Microbiol       Date:  2002-03       Impact factor: 3.501

Review 3.  Antigenic variation in trypanosomes: enhanced phenotypic variation in a eukaryotic parasite.

Authors:  J D Barry; R McCulloch
Journal:  Adv Parasitol       Date:  2001       Impact factor: 3.870

4.  Emergence of Anaplasma marginale antigenic variants during persistent rickettsemia.

Authors:  D M French; W C Brown; G H Palmer
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

5.  Specific expression of Anaplasma marginale major surface protein 2 salivary gland variants occurs in the midgut and is an early event during tick transmission.

Authors:  Christiane V Löhr; Fred R Rurangirwa; Terry F McElwain; David Stiller; Guy H Palmer
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

6.  Antigenic variation of Anaplasma marginale: major surface protein 2 diversity during cyclic transmission between ticks and cattle.

Authors:  A F Barbet; J Yi; A Lundgren; B R McEwen; E F Blouin; K M Kocan
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

7.  Highly conserved regions of the immunodominant major surface protein 2 of the genogroup II ehrlichial pathogen Anaplasma marginale are rich in naturally derived CD4+ T lymphocyte epitopes that elicit strong recall responses.

Authors:  W C Brown; T C McGuire; D Zhu; H A Lewin; J Sosnow; G H Palmer
Journal:  J Immunol       Date:  2001-01-15       Impact factor: 5.422

Review 8.  Switching trypanosome coats: what's in the wardrobe?

Authors:  Jesse E Taylor; Gloria Rudenko
Journal:  Trends Genet       Date:  2006-08-14       Impact factor: 11.639

9.  Antigenic variation of Anaplasma marginale by expression of MSP2 mosaics.

Authors:  A F Barbet; A Lundgren; J Yi; F R Rurangirwa; G H Palmer
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

Review 10.  Antigenic variation in vector-borne pathogens.

Authors:  A G Barbour; B I Restrepo
Journal:  Emerg Infect Dis       Date:  2000 Sep-Oct       Impact factor: 6.883
View more
  11 in total

1.  Evolution of antigen variation in the tick-borne pathogen Anaplasma phagocytophilum.

Authors:  Daniel Rejmanek; Patrick Foley; Anthony Barbet; Janet Foley
Journal:  Mol Biol Evol       Date:  2011-09-28       Impact factor: 16.240

2.  Anaplasma phagocytophilum MSP2(P44)-18 predominates and is modified into multiple isoforms in human myeloid cells.

Authors:  Madhubanti Sarkar; Matthew J Troese; Sarah A Kearns; Tian Yang; Dexter V Reneer; Jason A Carlyon
Journal:  Infect Immun       Date:  2008-02-19       Impact factor: 3.441

3.  The immunization-induced antibody response to the Anaplasma marginale major surface protein 2 and its association with protective immunity.

Authors:  Susan M Noh; Yan Zhuang; James E Futse; Wendy C Brown; Kelly A Brayton; Guy H Palmer
Journal:  Vaccine       Date:  2010-03-01       Impact factor: 3.641

Review 4.  'Nothing is permanent but change'- antigenic variation in persistent bacterial pathogens.

Authors:  Guy H Palmer; Troy Bankhead; Sheila A Lukehart
Journal:  Cell Microbiol       Date:  2009-08-25       Impact factor: 3.715

5.  Antigenic Variation in Bacterial Pathogens.

Authors:  Guy H Palmer; Troy Bankhead; H Steven Seifert
Journal:  Microbiol Spectr       Date:  2016-02

6.  Maintenance of antibody to pathogen epitopes generated by segmental gene conversion is highly dynamic during long-term persistent infection.

Authors:  Yan Zhuang; James E Futse; Wendy C Brown; Kelly A Brayton; Guy H Palmer
Journal:  Infect Immun       Date:  2007-09-04       Impact factor: 3.441

7.  Generation of antigenic variants via gene conversion: Evidence for recombination fitness selection at the locus level in Anaplasma marginale.

Authors:  James E Futse; Kelly A Brayton; Seth D Nydam; Guy H Palmer
Journal:  Infect Immun       Date:  2009-06-01       Impact factor: 3.441

8.  Expansion of variant diversity associated with a high prevalence of pathogen strain superinfection under conditions of natural transmission.

Authors:  Massaro W Ueti; Yunbing Tan; Shira L Broschat; Elizabeth J Castañeda Ortiz; Minerva Camacho-Nuez; Juan J Mosqueda; Glen A Scoles; Matthew Grimes; Kelly A Brayton; Guy H Palmer
Journal:  Infect Immun       Date:  2012-05-14       Impact factor: 3.441

Review 9.  Antigenic variation and transmission fitness as drivers of bacterial strain structure.

Authors:  Guy H Palmer; Kelly A Brayton
Journal:  Cell Microbiol       Date:  2013-08-28       Impact factor: 3.715

10.  Expression patterns of Anaplasma marginale Msp2 variants change in response to growth in cattle, and tick cells versus mammalian cells.

Authors:  Adela S Oliva Chávez; Roderick F Felsheim; Timothy J Kurtti; Pei-Shin Ku; Kelly A Brayton; Ulrike G Munderloh
Journal:  PLoS One       Date:  2012-04-25       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.